GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Inventory-to-Revenue

Optimind Pharma (XCNQ:OMND) Inventory-to-Revenue : 0.00 (As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Optimind Pharma's Average Total Inventories for the quarter that ended in Nov. 2023 was C$0.00 Mil. Optimind Pharma's Revenue for the three months ended in Nov. 2023 was C$0.03 Mil. Optimind Pharma's Inventory-to-Revenue for the quarter that ended in Nov. 2023 was 0.00.

Optimind Pharma's Inventory-to-Revenue for the quarter that ended in Nov. 2023 stayed the same from Aug. 2023 (0.00) to Aug. 2023 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Optimind Pharma Inventory-to-Revenue Historical Data

The historical data trend for Optimind Pharma's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Inventory-to-Revenue Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23
Inventory-to-Revenue
- -

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Inventory-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Optimind Pharma's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Optimind Pharma's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optimind Pharma's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimind Pharma's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Optimind Pharma's Inventory-to-Revenue falls into.



Optimind Pharma Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Optimind Pharma's Inventory-to-Revenue for the fiscal year that ended in Feb. 2023 is calculated as

Inventory-to-Revenue (A: Feb. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Feb. 2022 ) + Total Inventories (A: Feb. 2023 )) / count ) / Revenue (A: Feb. 2023 )
=( (0 + 0) / 1 ) / 0.17
=0 / 0.17
=0.00

Optimind Pharma's Inventory-to-Revenue for the quarter that ended in Nov. 2023 is calculated as

Inventory-to-Revenue (Q: Nov. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Aug. 2023 ) + Total Inventories (Q: Nov. 2023 )) / count ) / Revenue (Q: Nov. 2023 )
=( (0 + 0) / 1 ) / 0.027
=0 / 0.027
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optimind Pharma  (XCNQ:OMND) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Optimind Pharma's Days Inventory for the three months ended in Nov. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Nov. 2023 )/Cost of Goods Sold (Q: Nov. 2023 )*Days in Period
=0/0*365 / 4
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Optimind Pharma's Inventory Turnover for the quarter that ended in Nov. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Nov. 2023 ) / Average Total Inventories (Q: Nov. 2023 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optimind Pharma Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimind Pharma (XCNQ:OMND) Business Description

Traded in Other Exchanges
N/A
Address
3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines